Metabolomics biomarkers and the risk of overall mortality and ESRD in CKD: Results from the Progredir Cohort

INTRODUCTION: Studies on metabolomics and CKD have primarily addressed CKD incidence defined as a decline on eGFR or appearance of albuminuria in the general population, with very few evaluating hard outcomes. In the present study, we investigated the association between metabolites and mortality an...

Descripción completa

Detalles Bibliográficos
Autores principales: Titan, Silvia M., Venturini, Gabriela, Padilha, Kallyandra, Goulart, Alessandra C., Lotufo, Paulo A., Bensenor, Isabela J., Krieger, Jose E., Thadhani, Ravi I., Rhee, Eugene P., Pereira, Alexandre C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422295/
https://www.ncbi.nlm.nih.gov/pubmed/30883578
http://dx.doi.org/10.1371/journal.pone.0213764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422295/
https://www.ncbi.nlm.nih.gov/pubmed/30883578
http://dx.doi.org/10.1371/journal.pone.0213764

Ejemplares similares